SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5bqm'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XOZ_A_CIAA501_1
(CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE)
5bqm SOMATOLIBERIN,BOTULI
NUM NEUROTOXIN TYPE
D

(Clostridium
botulinum;
Homo
sapiens)
5 / 12 ALA B 799
ILE B 800
ILE B 640
PHE B 643
PHE B 671
None
0.89A 1xozA-5bqmB:
undetectable
1xozA-5bqmB:
20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1YC2_A_NCAA506_0
(NAD-DEPENDENT
DEACETYLASE 2)
5bqm SOMATOLIBERIN,BOTULI
NUM NEUROTOXIN TYPE
D

(Clostridium
botulinum;
Homo
sapiens)
4 / 6 SER B 646
PHE B 643
ASN B 674
ASP B 670
None
0.99A 1yc2A-5bqmB:
undetectable
1yc2A-5bqmB:
20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NYR_B_SVRB401_4
(NAD-DEPENDENT
DEACETYLASE
SIRTUIN-5)
5bqm SOMATOLIBERIN,BOTULI
NUM NEUROTOXIN TYPE
D

(Clostridium
botulinum;
Homo
sapiens)
4 / 5 ALA B 633
ALA B 799
ALA B 802
VAL B 621
None
0.86A 2nyrB-5bqmB:
undetectable
2nyrB-5bqmB:
17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_2
(ADENOSYLHOMOCYSTEINA
SE)
5bqm SOMATOLIBERIN,BOTULI
NUM NEUROTOXIN TYPE
D

(Clostridium
botulinum;
Homo
sapiens)
4 / 4 LEU B 647
GLN B 615
THR B 642
THR B 672
None
1.44A 2zj0D-5bqmB:
undetectable
2zj0D-5bqmB:
21.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GWX_A_EPAA1_1
(PROTEIN (PEROXISOME
PROLIFERATOR
ACTIVATED RECEPTOR
(PPAR-DELTA)))
5bqm SOMATOLIBERIN,BOTULI
NUM NEUROTOXIN TYPE
D

(Clostridium
botulinum;
Homo
sapiens)
5 / 10 ILE B 834
LEU B 647
VAL B 667
VAL B 651
LEU B 626
None
1.06A 3gwxA-5bqmB:
undetectable
3gwxA-5bqmB:
20.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3I45_A_NIOA500_1
(TWIN-ARGININE
TRANSLOCATION
PATHWAY SIGNAL
PROTEIN)
5bqm SOMATOLIBERIN,BOTULI
NUM NEUROTOXIN TYPE
D

(Clostridium
botulinum;
Homo
sapiens)
4 / 8 SER B 614
GLU B 631
TYR B 611
LEU B 705
None
0.96A 3i45A-5bqmB:
undetectable
3i45A-5bqmB:
21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_C_ZPCC1318_1
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)
5bqm SOMATOLIBERIN,BOTULI
NUM NEUROTOXIN TYPE
D

(Clostridium
botulinum;
Homo
sapiens)
5 / 12 VAL B 630
ILE B 700
GLU B 723
TYR B 605
VAL B 513
None
1.25A 4a97B-5bqmB:
3.6
4a97C-5bqmB:
undetectable
4a97B-5bqmB:
20.74
4a97C-5bqmB:
20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4PE5_B_QELB920_1
(GLUTAMATE RECEPTOR
IONOTROPIC, NMDA 1
GLUTAMATE RECEPTOR
IONOTROPIC, NMDA 2B)
5bqm SOMATOLIBERIN,BOTULI
NUM NEUROTOXIN TYPE
D

(Clostridium
botulinum;
Homo
sapiens)
5 / 10 TYR B 641
THR B 627
LEU B 644
ALA B 799
ILE B 640
None
1.44A 4pe5A-5bqmB:
0.4
4pe5B-5bqmB:
undetectable
4pe5A-5bqmB:
20.66
4pe5B-5bqmB:
20.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DHB_A_BEZA202_0
(HEPATITIS A VIRUS
CELLULAR RECEPTOR 2)
5bqm SOMATOLIBERIN,BOTULI
NUM NEUROTOXIN TYPE
D

(Clostridium
botulinum;
Homo
sapiens)
4 / 6 ARG B 759
ILE B 862
ASN B 866
ASP B 869
None
1.30A 6dhbA-5bqmB:
undetectable
6dhbA-5bqmB:
13.28